We asked four neurologists which symptoms you should never ignore—and what they might signal.

The WHO found low-income countries have 80 times fewer neurologists than high-income countries.

The study found that participants using GLP-1s were less likely to develop substance-use disorders or to have bad outcomes like overdosing. This comes at a time when manufacturers of these medications ...

For one woman, the road to answers ran through five different doctors before anyone thought to look inside her skull. Her ...

Neurological diseases are now the leading cause of poor health and disability worldwide. An estimated 3.4 billion people, or 40% of the world’s population, are affected by neurological disorders such ...

Neurological disorders affect over a third of the global population, presenting immense challenges for patients worldwide. Merz Therapeutics, a leading player in specialty neurology, aims to deliver ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

Early prediction and identification of neurodegenerative diseases offers the best chance for prevention and treatment.

Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or Parkinson's disease regain control of movement.